Loading
Latest filing published 02 Sept 2026 for BIOMERIEUX.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Celine Martin Roger Dalbert on record concern Biomerieux, in the capacity of senior executive. Over a trading history stretching from 9 September 2025 to 31 August 2026, the count stands at 4 filings.
In open-market terms, that means 1 purchase on one side and 2 sales worth €208k on the other. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. In 2026 alone, the filings show 1 purchase and 1 sale.
The record was last updated on 2 September 2026 with an open-market sale (€38k) in Biomerieux. The last insider purchase was made public on 2 September 2026, 51 days ago. Filings reach the AMF feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations